Are these pricey new Alzheimer’s drugs worth it?

July 24, 2023

Breakthrough new drugs that clear amyloid beta plaques from the brain are shaking up the field of Alzheimer’s disease research.

Lengthy screen time associated with childhood development delays
The amount of screen time spent by one-year-olds is associated with developmental delays. This finding, by researchers at Tohoku University, with collaborators at Hamamatsu University School of Medicine, was published in the journal JAMA Pediatrics.
Medicines360's long and winding, $82 million road to create and distribute $50 birth control
Drugs and medical devices rarely come from the nonprofit world. There are more than 2,600 for-profit pharmaceutical companies in the United States, but only three nonprofits have products on the American market.
LDL not the be all, end all in heart disease, heart attacks and stroke
Despite advances in treatment for high cholesterol, heart disease remains the leading cause of death in the U.S. Scientists at the Medical College of Wisconsin (MCW) are investigating the role of a form of cholesterol called very-low-density lipoprotein—and their findings may lead to new treatment options in the future.
Software analyzes calcium 'sparks' that can contribute to arrhythmia
A team of UC Davis and University of Oxford researchers have developed an innovative tool: SparkMaster 2. The open-source software allows scientists to analyze normal and abnormal calcium signals in cells automatically.
Precarious employment conditions can increase risk of early death
People without a secure job contract can reduce their risk of premature death by 20 percent if they gain permanent employment, a study from Karolinska Institutet published in the Journal of Epidemiology and Community Health reports. According to the researchers, the results indicate that job security on the Swedish labor market needs to improve.

Are these pricey new Alzheimer’s drugs worth it?

Recent Posts

JUST IN